Sign In
Buy MDRX
$4.80
-0.200 (-4.00%)
At Close: Jul 31, 2026
Will (MDRX) Beat Estimates Again in Its Next Earnings Report?
01:33pm, Friday, 03'rd Feb 2023
(MDRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MDRX or VERI: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 01'st Feb 2023
MDRX vs. VERI: Which Stock Is the Better Value Option?
Strength Seen in Veradigm (MDRX): Can Its 5.0% Jump Turn into More Strength?
09:02am, Thursday, 12'th Jan 2023
Veradigm (MDRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
Here's Why You Should Retain Veradigm (MDRX) Stock for Now
12:02pm, Tuesday, 10'th Jan 2023
Investors continue to be optimistic about Veradigm (MDRX) owing to its strategic alliances.
Veradigm to Present at the 2023 J.P. Morgan Healthcare Conference
08:01am, Friday, 06'th Jan 2023
CHICAGO--( BUSINESS WIRE )--Veradigm Inc. (Nasdaq:MDRX), formerly Allscripts Healthcare Solutions Inc., announced today that Rick Poulton, Veradigm Chief Executive Officer, will present at the 2023 J.
3 Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
12:02pm, Wednesday, 07'th Dec 2022
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
Allscripts Healthcare Solutions: The Picture Is Improving
12:17pm, Tuesday, 22'nd Nov 2022
Allscripts Healthcare Solutions has done well to post sales and cash flow growth in recent quarters. The company still faces uncertainty and risks moving forward, but it's healthy and trading on the c
Allscripts Healthcare Solutions, Inc. (MDRX) Q3 2022 Earnings Call Transcript
04:59pm, Saturday, 05'th Nov 2022
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Jenny Gelinas - VP, IR Richard Poulton - CEO Thomas Langan - Pres
Allscripts (MDRX) Q3 Earnings Surpass Estimates, Margins Up
11:18am, Friday, 04'th Nov 2022
Allscripts' (MDRX) robust Q3 results demonstrate strength in both segments.
AllScripts Healthcare (MDRX) Q3 Earnings Top Estimates
06:48pm, Thursday, 03'rd Nov 2022
AllScripts (MDRX) delivered earnings and revenue surprises of 21.05% and 0.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
01:32pm, Monday, 10'th Oct 2022
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
MDRX vs. OMCL: Which Stock Is the Better Value Option?
12:47pm, Wednesday, 05'th Oct 2022
MDRX vs. OMCL: Which Stock Is the Better Value Option?
MDRX vs. OMCL: Which Stock Should Value Investors Buy Now?
12:47pm, Tuesday, 09'th Aug 2022
MDRX vs. OMCL: Which Stock Is the Better Value Option?
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Rick Poulton on Q2 2022 Results - Earnings Call Transcript
08:02pm, Sunday, 07'th Aug 2022
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Jenny Gelinas - VP, IR Rick Poulton - CEO Tom Langan - President an
AllScripts Healthcare (MDRX) Tops Q2 Earnings and Revenue Estimates
07:33pm, Thursday, 04'th Aug 2022
AllScripts (MDRX) delivered earnings and revenue surprises of 12.50% and 2.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
